Prevalence and Impact of Relapse in Patients With Schizophrenia.

IF 4.5 2区医学 Q1 PSYCHIATRY

Journal of Clinical Psychiatry Pub Date : 2020-03-24 DOI:10.4088/JCP.MS19053BR1C

John Lauriello

引用次数: 8

Abstract

Many individuals with schizophrenia experience multiple relapses, which are associated with serious and potentially fatal outcomes. Nonadherence to antipsychotic medications is a major contributor to relapse. By using reliable strategies to measure adherence and identify patients who are not taking their medications as prescribed, clinicians can intervene to possibly prevent relapse or decrease its severity.

查看原文本刊更多论文

精神分裂症患者复发的患病率和影响。

许多精神分裂症患者经历多次复发，这与严重和潜在致命的后果有关。不坚持服用抗精神病药物是复发的主要原因。通过使用可靠的策略来衡量依从性，并确定没有按规定服药的患者，临床医生可以进行干预，以防止复发或降低其严重程度。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Clinical Psychiatry 医学-精神病学

CiteScore

7.40

自引率

1.90%

发文量

审稿时长

3-8 weeks

期刊介绍： For over 75 years, The Journal of Clinical Psychiatry has been a leading source of peer-reviewed articles offering the latest information on mental health topics to psychiatrists and other medical professionals.The Journal of Clinical Psychiatry is the leading psychiatric resource for clinical information and covers disorders including depression, bipolar disorder, schizophrenia, anxiety, addiction, posttraumatic stress disorder, and attention-deficit/hyperactivity disorder while exploring the newest advances in diagnosis and treatment.